guidelines.wfh.orgGuidelines – World Federation of

Hemophilia WFH NETWORK Menu WFH WFH USA TREATMENT GUIDELINES RESOURCE HUB WORLD CONGRESS WFH EVENTS ELEARNING HEMOPHILIA WORLD NEWS WFH NETWORK WFH WFH USA TREATMENT GUIDELINES RESOURCE HUB WORLD CONGRESS WFH EVENTS ELEARNING HEMOPHILIA WORLD NEWS Menu WFH WFH USA TREATMENT GUIDELINES RESOURCE HUB WORLD CONGRESS WFH EVENTS ELEARNING HEMOPHILIA WORLD NEWS En Fr Es 简体中文 Русский العربية Overview of the WFH Treatment Guidelines Glenn Pierce, MD, PhD WFH Vice President, Medical The World Federation of Hemophilia has published the third edition of Guidelines for the Management of Hemophilia. Developed through a formal evidence-informed and consensus-based methodology involving multidisciplinary healthcare professionals (HCPs) and well-informed people with hemophilia (PWH), these guidelines offer 340 practical recommendations on managing care for PWH. The guidance provides a framework for the development of a comprehensive healthcare system supporting PWH, including advocacy and patient empowerment. Narrated video Download the full guidelines Browse by chapter 1. Principles of care 2. Comprehensive care of hemophilia 3. Laboratory diagnosis and monitoring 4. Genetic assessment 5. Hemostatic agents 6. Prophylaxis in hemophilia 7. Treatment of specific hemorrhages 8. Inhibitors to clotting factor 9. Specific management issues 10. Musculoskeletal complications 11. Outcome assessment 12. Methodology Menu 1. Principles of care 2. Comprehensive care of hemophilia 3. Laboratory diagnosis and monitoring 4. Genetic assessment 5. Hemostatic agents 6. Prophylaxis in hemophilia 7. Treatment of specific hemorrhages 8. Inhibitors to clotting factor 9. Specific management issues 10. Musculoskeletal complications 11. Outcome assessment 12. Methodology Principles of care Chapter 01 Alok Srivastava MD, FRACP, FRCPA, FRCP Professor of Medicine Department of Haematology Head, Centre for Stem Cell Research Christian Medical College Vellore, India Comprehensive care of hemophilia Chapter 02 Kate Khair PhD Director of Research, Haemnet, London Centre for Outcomes and Experience Research in Children’s Health, Illness and Disability (ORCHID), Great Ormond Street Hospital for Children London, UK Laboratory diagnosis and monitoring Chapter 03 Steve Kitchen PhD Clinical Scientist Department of Coagulation Royal Hallamshire Hospital Sheffield, United Kingdom Genetic assessment Chapter 04 Megan Sutherland PhD Clinical Scientist Genomic Diagnostics Laboratory Manchester Center for Genomic Medicine Manchester University NHS Foundation Trust Saint Mary’s Hospital Manchester, United Kingdom Hemostatic agents Chapter 05 Steven W. Pipe MD Professor of Pediatrics and Pathology Laurence A. Boxer Research Professor of Pediatrics and Communicable Diseases Pediatric Director, Hemophilia and Coagulation Disorders Program Director, Special Coagulation Laboratory University of Michigan Ann Arbor, Michigan, United States Prophylaxis in hemophilia Chapter 06 Manuel Carcao MD, MSc Staff Haematologist Co-Director, Hemophilia Clinic Hospital for Sick Children Professor of Paediatrics University of Toronto Toronto, Ontario, Canada Treatment of specific hemorrhages Chapter 07 Johnny Mahlangu BSc, MBBCh, MMed, FCPath Clinical Haematologist, Charlotte Maxeke Johannesburg Academic Hospital and Department of Molecular Medicine and Haematology Professor in Haematology, Faculty of the Health Sciences University of the Witwatersrand and National Health Laboratory Service Johannesburg, South Africa Inhibitors to clotting factor Chapter 08 Margaret V. Ragni MD, MPH Professor of Medicine and Clinical Translational Science Department of Medicine, Division Hematology/Oncology University of Pittsburgh Medical Center Director, Hemophilia Center of Western PA Pittsburgh, PA Specific management issues Chapter 09 Jerzy Windyga PhD, MD Department of Hemostasis Disorders and Internal Medicine IHIT Instytut Hematologii I Transfuzjologii Warsaw, Poland Musculoskeletal complications Chapter 10 Adolfo Llinás MD Director Médico Fundacion Santa Fe de Bogota Bogota, D.C., Colombia Outcome assessment Chapter 11 Pradeep M. Poonnoose MD Professor, Department of Orthopaedics Christian Medical College Vellore, India Methodology Chapter 12 Sandra Zelman Lewis PhD President, EBQ Consulting, LLC Evidence-based Guidelines and Quality Improvement Northbrook, Illinois, USA These materials are derived from the WFH Guidelines for the Management of Hemophilia, 3rd edition [© 2020 World Federation of Hemophilia. Haemophilia © 2020 John Wiley & Sons Ltd] For the full set of recommendations, please refer to the full WFH Treatment Guidelines, available here . For questions, contact [email protected] These educational materials were made possible through the support of the Hemophilia Alliance. © World Federation of...